IB Net Payout Yields Model

Invest like me - only at Covestor.com

Trump Media: Excitement Set To Slump

By -

Updated - May 21, 2024

Trump Media & Technology Group actually reported a dip in revenues for Q1. In addition, the media company nearly listed more retail shareholders than revenues. Truth Social continues to have virtually no business, yet the stock only slumped to $44. 

  • Revenues fell to $770,500 from a year-ago $1.116M, and those sales largely came from the company's "nascent advertising initiative, which will continue to evolve as TMTG implements its vision," the company said.
  • Successfully Debuted as Public Company, and Now Has Over 621,000 Retail Shareholders.

Finviz Chart

Updated - April 8 

As expected, Trump Media is slumping after an initial burst following the consummation of the SPAC merger with Digital World. DJT is already down 50% from the initial highs. 

Finviz Chart


Original article published on April 2 

  • Trump Media & Technology Group Corp. completed its SPAC deal with Digital World Acquisition Corp, but shareholders now face major risks with the stock market shifting focus away from SPAC promises.
  • The business has done very little since launching in early 2021, with total 2023 revenue of only $4.1 million.
  • The stock has a fully diluted valuation of up to $10 billion despite weak financials and limited sings of innovation.
  • Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios. Learn More »
After a very lengthy process and a difficult road, Trump Media & Technology Group Corp., or TMTG, (NASDAQ:DJT) finally completed the SPAC deal with Digital World Acquisition Corp. As with most SPACs after completing business combinations, shareholders in the social media company now face major risks with the stock market shifting focus away from SPAC promises to the reality of the limited business in place. My investment thesis remains ultra Bearish with the stock still trading at nearly $50 despite updating the market with weak 2023 numbers and not providing much hope for 2024.

Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 

Comments

Post a Comment

Popular posts from this blog

Occidental: Still Producing Too Much Oil

By -
Image
Though oil continues plunging, the oil giants continue producing more. For Q4, Occidental Petroleum (OXY) had roughly flat production. The worst part is that OXY plans to grow production by 2% to 4% in 2016. The stock has held up somewhat strong, but the inability to turn off the spigot remains troubling. Disclosure: No positions mentioned. Please review the disclaimer page for more details. 
Read more

ChargePoint: Low Quality Beat

By -
Image
  ChargePoint beat FQ2'22 revenue estimates, but the losses are mounting. The company guided up FY22 numbers partly due to acquisitions. The stock still trades at an estimated 21x FY23 number leaving limited upside for the stock and reinforcing why venture funds sold 13.8 million shares. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.  Learn More » After  solid FQ2'22 earnings ,  ChargePoint Holdings  ( CHPT ) has seen a nice bump in the stock. Now investors have to confront the valuation divide and deal with the past insider sales likely leading to future sales on any stock rallies. My  investment thesis  remains very Bearish on the EV charging station stock on any rallies into the mid-$20s. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaimer page for more details.  Update - Sept. 8 Be cautious when analysts strugg...
Read more

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disc...
Read more